These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 23710976

  • 1. Central nervous system stimulants for secondary attention deficit-hyperactivity disorder after paediatric traumatic brain injury: a rationale and protocol for single patient (n-of-1) multiple cross-over trials.
    Senior HE, McKinlay L, Nikles J, Schluter PJ, Carmont SA, Waugh MC, Epps A, Lloyd O, Mitchell GK.
    BMC Pediatr; 2013 May 28; 13():89. PubMed ID: 23710976
    [Abstract] [Full Text] [Related]

  • 2. Aggregated n-of-1 trials of central nervous system stimulants versus placebo for paediatric traumatic brain injury--a pilot study.
    Nikles CJ, McKinlay L, Mitchell GK, Carmont SA, Senior HE, Waugh MC, Epps A, Schluter PJ, Lloyd OT.
    Trials; 2014 Feb 13; 15():54. PubMed ID: 24524676
    [Abstract] [Full Text] [Related]

  • 3. A series of n-of-1 trials of stimulants in brain injured children.
    Nikles J, Mitchell G, McKinlay L, Waugh MC, Epps A, Carmont SA, Schluter PJ, Lloyd O, Senior H.
    NeuroRehabilitation; 2017 Feb 13; 40(1):11-21. PubMed ID: 27814302
    [Abstract] [Full Text] [Related]

  • 4. Methylphenidate versus dexamphetamine in children with attention deficit hyperactivity disorder: A double-blind, crossover trial.
    Efron D, Jarman F, Barker M.
    Pediatrics; 1997 Dec 13; 100(6):E6. PubMed ID: 9382907
    [Abstract] [Full Text] [Related]

  • 5. An n-of-1 trial service in clinical practice: testing the effectiveness of stimulants for attention-deficit/hyperactivity disorder.
    Nikles CJ, Mitchell GK, Del Mar CB, Clavarino A, McNairn N.
    Pediatrics; 2006 Jun 13; 117(6):2040-6. PubMed ID: 16740846
    [Abstract] [Full Text] [Related]

  • 6. Methylphenidate treatment of attention-deficit/hyperactivity disorder secondary to traumatic brain injury: a critical appraisal of treatment studies.
    Jin C, Schachar R.
    CNS Spectr; 2004 Mar 13; 9(3):217-26. PubMed ID: 14999162
    [Abstract] [Full Text] [Related]

  • 7. A randomised controlled trial of the Neuro Emotional Technique (NET) for childhood Attention Deficit Hyperactivity Disorder (ADHD): a protocol.
    Karpouzis F, Pollard H, Bonello R.
    Trials; 2009 Jan 27; 10():6. PubMed ID: 19173743
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of lisdexamfetamine dimesylate throughout the day in children and adolescents with attention-deficit/hyperactivity disorder: results from a randomized, controlled trial.
    Coghill DR, Banaschewski T, Lecendreux M, Zuddas A, Dittmann RW, Otero IH, Civil R, Bloomfield R, Squires LA.
    Eur Child Adolesc Psychiatry; 2014 Feb 27; 23(2):61-8. PubMed ID: 23708466
    [Abstract] [Full Text] [Related]

  • 9. A randomized, double-blind, crossover study of once-daily dexmethylphenidate in children with attention-deficit hyperactivity disorder: rapid onset of effect.
    Brams M, Muniz R, Childress A, Giblin J, Mao A, Turnbow J, Borrello M, McCague K, Lopez FA, Silva R.
    CNS Drugs; 2008 Feb 27; 22(8):693-704. PubMed ID: 18601306
    [Abstract] [Full Text] [Related]

  • 10. Clinical gains from including both dextroamphetamine and methylphenidate in stimulant trials.
    Ramtvedt BE, Røinås E, Aabech HS, Sundet KS.
    J Child Adolesc Psychopharmacol; 2013 Nov 27; 23(9):597-604. PubMed ID: 23659360
    [Abstract] [Full Text] [Related]

  • 11. Medium-term outcomes are comparable with short-term outcomes in children with attention deficit hyperactivity disorder treated with stimulant medication.
    Efron D, Jarman FC, Barker MJ.
    J Paediatr Child Health; 2000 Oct 27; 36(5):457-61. PubMed ID: 11036801
    [Abstract] [Full Text] [Related]

  • 12. Methylphenidate for attention-deficit/hyperactivity disorder in children and adolescents: Cochrane systematic review with meta-analyses and trial sequential analyses of randomised clinical trials.
    Storebø OJ, Krogh HB, Ramstad E, Moreira-Maia CR, Holmskov M, Skoog M, Nilausen TD, Magnusson FL, Zwi M, Gillies D, Rosendal S, Groth C, Rasmussen KB, Gauci D, Kirubakaran R, Forsbøl B, Simonsen E, Gluud C.
    BMJ; 2015 Nov 25; 351():h5203. PubMed ID: 26608309
    [Abstract] [Full Text] [Related]

  • 13. Buspirone versus methylphenidate in the treatment of children with attention- deficit/ hyperactivity disorder: randomized double-blind study.
    Mohammadi MR, Hafezi P, Galeiha A, Hajiaghaee R, Akhondzadeh S.
    Acta Med Iran; 2012 Nov 25; 50(11):723-8. PubMed ID: 23292622
    [Abstract] [Full Text] [Related]

  • 14. A double-blind, placebo-controlled study of modified-release methylphenidate in children with attention-deficit/hyperactivity disorder.
    Greenhill LL, Findling RL, Swanson JM, ADHD Study Group.
    Pediatrics; 2002 Mar 25; 109(3):E39. PubMed ID: 11875167
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of a novel biphasic controlled-release methylphenidate formula in adults with attention-deficit/hyperactivity disorder: results of a double-blind, placebo-controlled crossover study.
    Jain U, Hechtman L, Weiss M, Ahmed TS, Reiz JL, Donnelly GA, Harsanyi Z, Darke AC.
    J Clin Psychiatry; 2007 Feb 25; 68(2):268-77. PubMed ID: 17335326
    [Abstract] [Full Text] [Related]

  • 16. Continued Benefits of Methylphenidate in ADHD After 2 Years in Clinical Practice: A Randomized Placebo-Controlled Discontinuation Study.
    Matthijssen AM, Dietrich A, Bierens M, Kleine Deters R, van de Loo-Neus GHH, van den Hoofdakker BJ, Buitelaar JK, Hoekstra PJ.
    Am J Psychiatry; 2019 Sep 01; 176(9):754-762. PubMed ID: 31109200
    [Abstract] [Full Text] [Related]

  • 17. Minimizing adverse events while maintaining clinical improvement in a pediatric attention-deficit/hyperactivity disorder crossover trial with dextroamphetamine and methylphenidate.
    Ramtvedt BE, Aabech HS, Sundet K.
    J Child Adolesc Psychopharmacol; 2014 Apr 01; 24(3):130-9. PubMed ID: 24666268
    [Abstract] [Full Text] [Related]

  • 18. Short-term efficacy and tolerability of methylphenidate in children with traumatic brain injury and attention problems.
    Ekinci O, Direk MÇ, Gunes S, Teke H, Ekinci N, Yıldırım F, Okuyaz Ç.
    Brain Dev; 2017 Apr 01; 39(4):327-336. PubMed ID: 27903419
    [Abstract] [Full Text] [Related]

  • 19. Methylphenidate for attention-deficit/hyperactivity disorder in patients with Smith-Magenis syndrome: protocol for a series of N-of-1 trials.
    Müller AR, Zinkstok JR, Rommelse NNJ, van de Ven PM, Roes KCB, Wijburg FA, de Rooij-Askes E, Linders C, Boot E, van Eeghen AM.
    Orphanet J Rare Dis; 2021 Sep 08; 16(1):380. PubMed ID: 34496899
    [Abstract] [Full Text] [Related]

  • 20. Managing ADHD in general practice. N of 1 trials can help!
    Duggan CM, Mitchell G, Nikles CJ, Glasziou PP, Del Mar CB, Clavarino A.
    Aust Fam Physician; 2000 Dec 08; 29(12):1205-9. PubMed ID: 11140235
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.